These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7880319)

  • 1. Short-term course of renal function in accelerated hypertension.
    Kadiri S; Olutade BO
    Afr J Med Med Sci; 1993 Mar; 22(1):25-9. PubMed ID: 7880319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ; Koopmans RP; van Montfrans GA
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The short-term course of renal function in malignant hypertensives with renal insufficiency.
    Lawton WJ
    Clin Nephrol; 1982 Jun; 17(6):277-83. PubMed ID: 7105502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery bypass grafting in non-dialysis-dependent mild-to-moderate renal dysfunction.
    Weerasinghe A; Hornick P; Smith P; Taylor K; Ratnatunga C
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1083-9. PubMed ID: 11385375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy.
    Rocha-Singh KJ; Ahuja RK; Sung CH; Rutherford J
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):135-41. PubMed ID: 12357507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis in malignant or accelerated hypertension.
    Guerin C; Gonthier R; Berthoux FC
    Nephrol Dial Transplant; 1988; 3(1):33-7. PubMed ID: 3132637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of 24-h ambulatory blood pressure measurement in a routine clinical setting of patients with chronic renal disease.
    Jacob P; Hartung R; Bohlender J; Stein G
    J Hum Hypertens; 2004 Oct; 18(10):745-51. PubMed ID: 15103314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of renal failure on liver transplantation survival.
    Afonso RC; Hidalgo R; Zurstrassen MP; Fonseca LE; Pandullo FL; Rezende MB; Meira-Filho SP; Ferraz-Neto BH
    Transplant Proc; 2008 Apr; 40(3):808-10. PubMed ID: 18455024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischaemic heart disease is a risk factor for renal failure after heart transplantation.
    Hosková L; Viklický O; Málek I; Podzimková M; Hegarová M; Pirk J; Vítko S; Kautzner J
    Int J Cardiol; 2008 Jan; 123(3):358-60. PubMed ID: 17360057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CRP levels in pre-dialysis patients.
    Razeghi E; Parkhideh S; Ahmadi F; Khashayar P
    Ren Fail; 2008; 30(2):193-8. PubMed ID: 18300120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Tc-99 measurement of glomerular filtration rate vs. calculated creatinine clearance to assess renal function pretransplant in pediatric patients undergoing hematopoietic stem cell transplantation.
    Kletzel M; Pirich L; Haut P; Cohn RA
    Pediatr Transplant; 2005 Oct; 9(5):584-8. PubMed ID: 16176414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant arterial hypertension. Relationship between blood pressure control and renal function during long-term observation of patients with malignant nephrosclerosis.
    Jespersen B; Eiskjaer H; Christiansen NO; Olsen S; Pedersen EB
    J Clin Hypertens; 1987 Dec; 3(4):409-18. PubMed ID: 3453383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute renal failure associated with malignant hypertension].
    Gassanov N; Pollok M; Er F
    Dtsch Med Wochenschr; 2009 Oct; 134(44):2224-7. PubMed ID: 19847731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of arterial hypertension in progression of renal failure.
    Kes P; Ratković-Gusić I
    Kidney Int Suppl; 1996 Jun; 55():S72-4. PubMed ID: 8743515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.